A Phase II, Randomized, Double-Blind, Parallel Group, Acyclovir-Controlled Study to Evaluate ZEP-3 Ointment for the Treatment of Cold Sores (Herpes Labialis).
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2016
At a glance
- Drugs ZEP 3 (Primary) ; Aciclovir
- Indications Herpes labialis
- Focus Therapeutic Use
- Sponsors SIS Shulov Innovative Science
- 29 Sep 2015 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016 as per ClinicalTrials.gov record.
- 29 Sep 2015 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016 as per ClinicalTrials.gov record.
- 29 Sep 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.